575 related articles for article (PubMed ID: 18392331)
1. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
Ji WR; Barrientos LG; LlinĂ¡s M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
[TBL] [Abstract][Full Text] [Related]
3. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
5. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
[TBL] [Abstract][Full Text] [Related]
6. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
O'Reilly MS
EXS; 1997; 79():273-94. PubMed ID: 9002223
[TBL] [Abstract][Full Text] [Related]
7. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
[TBL] [Abstract][Full Text] [Related]
8. Enhanced anti-angiogenic effect of a deletion mutant of plasminogen kringle 5 on neovascularization.
Cai W; Ma J; Li C; Yang Z; Yang X; Liu W; Liu Z; Li M; Gao G
J Cell Biochem; 2005 Dec; 96(6):1254-61. PubMed ID: 16167344
[TBL] [Abstract][Full Text] [Related]
9. High level expression of kringle 5 fragment of plasminogen in Pichia pastoris.
Zhou Y; Zheng Q; Gao J; Gu J
Biotechnol Lett; 2005 Feb; 27(3):167-71. PubMed ID: 15717125
[TBL] [Abstract][Full Text] [Related]
10. Expression of the non-glycosylated kringle domain of tissue type plasminogen activator in Pichia and its anti-endothelial cell activity.
Lee SB; Oh HK; Kim HK; Joe YA
Protein Expr Purif; 2006 Nov; 50(1):1-8. PubMed ID: 16854593
[TBL] [Abstract][Full Text] [Related]
11. Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity.
Lee H; Kim HK; Lee JH; You WK; Chung SI; Chang SI; Park MH; Hong YK; Joe YA
Arch Biochem Biophys; 2000 Mar; 375(2):359-63. PubMed ID: 10700393
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
[TBL] [Abstract][Full Text] [Related]
13. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells.
Lu H; Dhanabal M; Volk R; Waterman MJ; Ramchandran R; Knebelmann B; Segal M; Sukhatme VP
Biochem Biophys Res Commun; 1999 May; 258(3):668-73. PubMed ID: 10329443
[TBL] [Abstract][Full Text] [Related]
14. Secreted human apolipoprotein(a) kringle IV-10 and kringle V inhibit angiogenesis and xenografted tumor growth.
Shen L; Zhu X; Wang Y; Zeng W; Wu G; Xue H; Chen B
Biol Chem; 2008 Feb; 389(2):135-41. PubMed ID: 18163888
[TBL] [Abstract][Full Text] [Related]
15. A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer.
Matsuda KM; Madoiwa S; Hasumi Y; Kanazawa T; Saga Y; Kume A; Mano H; Ozawa K; Matsuda M
Cancer Gene Ther; 2000 Apr; 7(4):589-96. PubMed ID: 10811477
[TBL] [Abstract][Full Text] [Related]
16. Expression of recombinant kringle 1-5 domains of human plasminogen by a prokaryote expression system.
Hou WH; Fang T; Chai YR; Wang TY; Wang JM; Xue LX
Protein Expr Purif; 2006 May; 47(1):93-8. PubMed ID: 16510293
[TBL] [Abstract][Full Text] [Related]
17. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin.
Nam JO; Jeong HW; Lee BH; Park RW; Kim IS
Cancer Res; 2005 May; 65(10):4153-61. PubMed ID: 15899806
[TBL] [Abstract][Full Text] [Related]
18. A novel strategy for the generation of angiostatic kringle regions from a precursor derived from plasminogen.
Schmitz V; Wang L; Barajas M; Peng D; Prieto J; Qian C
Gene Ther; 2002 Dec; 9(23):1600-6. PubMed ID: 12424612
[TBL] [Abstract][Full Text] [Related]
19. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
[TBL] [Abstract][Full Text] [Related]
20. Angiostatic activity of human plasminogen fragments is highly dependent on glycosylation.
Santos IC; Silbiger VN; Higuchi DA; Gomes MA; Barcelos LS; Teixeira MM; Lopes MT; Cardoso VN; Lima MP; Araujo RC; Pesquero JB; Pesquero JL
Cancer Sci; 2010 Feb; 101(2):453-9. PubMed ID: 19961492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]